Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation

Abstract

Our findings provide putative metabolite biomarkers for future study and allow for hypothesis generation about the pathophysiology of CF pulmonary exacerbation.